10.1371/journal.pone.0141137.g006
Harry A. Quigley
Harry
A. Quigley
Ian F. Pitha
Ian
F. Pitha
Derek S. Welsbie
Derek
S. Welsbie
Cathy Nguyen
Cathy
Nguyen
Matthew R. Steinhart
Matthew
R. Steinhart
Thao D. Nguyen
Thao D.
Nguyen
Mary Ellen Pease
Mary
Ellen Pease
Ericka N. Oglesby
Ericka
N. Oglesby
Cynthia A. Berlinicke
Cynthia
A. Berlinicke
Katherine L. Mitchell
Katherine
L. Mitchell
Jessica Kim
Jessica
Kim
Joan J. Jefferys
Joan
J. Jefferys
Elizabeth C. Kimball
Elizabeth
C. Kimball
RTPCR of angiotensin receptor expression.
Public Library of Science
2015
IOP.ConclusionsThe neuroprotective effect
tail cuff device
transcription polymerase chain reaction
RGC loss
angiotensin receptors
3 day IOP elevations
control glaucoma eyes
scleral thickness
regression model p
enalapril
blood pressure
Experimental Glaucoma PurposeTo
Alters Scleral Remodeling
CD 1 mice
Losartan Treatment Protects Retinal Ganglion Cells
losartan treatment decreases
Axonal transport blockade
2015-10-27 03:50:48
Figure
https://plos.figshare.com/articles/figure/_RTPCR_of_angiotensin_receptor_expression_/1586590
<p>Graph plots the relative expression of five tissues tested for the presence of AT1a, AT1b, and AT2 receptors- kidney, adrenal gland, retina, sclera and optic nerve from a CD1 mouse. To help normalize the results, a value was calculated by dividing the GAPDH primer treated tissue value by the mean quantification cycle (Cq) value for AT1A, AT1B, or AT2 primer tissue (relative expression). A lower value than 1 indicates a lower value for that receptor in tissue compared to GAPDH.</p>